Patent directory · USPTO A61K / A61P
Patents matching “Lead Discovery Center GmbH”
12 pharma patents match "Lead Discovery Center GmbH" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 12 pharmaceutical patents matching "Lead Discovery Center GmbH" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12281079
Quinoline derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted -
US 12060362
Inhibitors of glucose transporters (GLUTs)
granted -
US 11945822
Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinase
granted -
US 11858937
Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors
granted -
US 11111238
Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted -
US 10934274
Quinoline derivatives as TAM RTK inhibitors
granted -
US 10703735
4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer
granted -
US 9567345
Pharmaceutically active pyrazolo-triazine derivatives
granted -
US 9453051
Cyclosporin derivatives
granted -
US 9242937
Pharmaceutically active disubstituted pyridine derivatives
granted -
US 9096608
Pharmaceutically active pyrazolo-triazine derivatives
granted -
US 8999982
Pharmaceutically active compounds as Axl inhibitors
granted